BioSpace News Archive

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, will host an analyst day in New York City on March 5, 2020.

Lipocine Inc. announced that it has entered into securities purchase agreements with certain institutional investors providing for the purchase and sale of 10,084,034 Class A Units at an offering price of $0.595 per unit, with each Class A Unit consisting of one share of its common stock and one-half of a common warrant to purchase one share of common stock at an exercise price of $0.53 per share of common stock, in a registered direct offering priced at-the-market.

SAN FRANCISCO and SHANGHAI, China, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) and WuXi Biologics (stock code: 2269.HK) today announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of COVID-19 (Coronavirus Disease 2019), a disease caused by SARS-CoV-2. Under the terms of the agreement, the companies will work together on the clinical development, manufacturing, and commercialization of

Panorama Medicine, a genomics and computing powered drug discovery company focusing on RNA-targeted therapeutics, announced the appointment of Jae Lee, PhD, as Executive Vice President, Research and Preclinical Development, effective February 24, and Maxine Gowen, PhD, as Board Director, effective January 1.

Global Research & Discovery Group Sciences, a private research and development organization, recently conducted an additional round of antiviral testing of Equivir confirming efficacy against a broad range of viruses.

Feb. 25, 2020 13:30 UTC FDA Grants IND Approval to Promising Anti-Cancer Agent Veyonda ® Current IND for sarcoma paves the way for future INDs for late-stage prostate cancer SYDNEY--( BUSINESS WIRE )-- Noxopharm (ASX: NOX) announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for Veyonda ® for combination treatment with doxorubicin in patients with soft tissue sarcomas. “Based on preclinical an

Primavera Essentials is extremely excited to announce their line of high-quality CBD products and a brand that is invested in educating the discriminating buyer.

MENLO PARK, Calif. , Feb. 25, 2020 /PRNewswire/ -- Anitoa Systems, a Silicon Valley biotech company has demonstrated a solution for rapid on-site nucleic acid test of the 2019 novel coronavirus (2019-nCoV). Anitoa combines a high performance ultra-portable Real Time Polymerase Chain Reaction (qPCR) instrument called Maverick, with an innovative “one-step” reverse transcription

TwinStrand Duplex Sequencing technology offers unprecedented accuracy of DNA analysis, which is available in easily adopted reagent kit and cloud-based software format that can be applied to broad applications across medicine and basic research.

LLS cautions consumers to be wary of short-term plans and urges state and federal policymakers to protect patients